Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort
暂无分享,去创建一个
J. Miro | J. Gatell | J. Caylà | C. Garriga | M. Gurguí | P. Domingo | M. Barberá | H. Knobel | I. Ocaña | E. Ribera | A. Marco | V. Humet | P. García de Olalla
[1] Katherine E Henson,et al. Risk of Suicide After Cancer Diagnosis in England , 2018, JAMA psychiatry.
[2] A. Zwinderman,et al. Changes in HIV RNA and CD4 Cell Count After Acute HCV Infection in Chronically HIV-Infected Individuals , 2015, Journal of acquired immune deficiency syndromes.
[3] P. Sogni,et al. Hepatitis B and human immunodeficiency virus co-infection. , 2014, World journal of gastroenterology.
[4] A. Mocroft,et al. Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[5] Jack Drescher,et al. Proposed declassification of disease categories related to sexual orientation in the International Statistical Classification of Diseases and Related Health Problems (ICD-11) , 2014, Bulletin of the World Health Organization.
[6] C. Garriga,et al. A low-cost, sustainable, second generation system for surveillance of people living with HIV in Spain: 10-year trends in behavioural and clinical indicators, 2002 to 2011. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[7] Madison,et al. Revised surveillance case definition for HIV infection--United States, 2014. , 2014, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[8] C. Larsen,et al. Employment status in persons with and without HIV infection in Denmark: 1996–2011 , 2014, AIDS.
[9] R. Paredes,et al. Adjudicated Morbidity and Mortality Outcomes by Age among Individuals with HIV Infection on Suppressive Antiretroviral Therapy , 2014, PloS one.
[10] L. Goodall,et al. Late diagnosis among our ageing HIV population: a cohort study , 2014, Journal of the International AIDS Society.
[11] C. Larsen,et al. Educational attainment and risk of HIV infection, response to antiretroviral treatment, and mortality in HIV-infected patients , 2014, AIDS.
[12] R. Hogg,et al. Gender Differences in Clinical Outcomes among HIV-Positive Individuals on Antiretroviral Therapy in Canada: A Multisite Cohort Study , 2013, PloS one.
[13] Fan Zhang,et al. Determinants of Progression to AIDS and Death Following HIV Diagnosis: A Retrospective Cohort Study in Wuhan, China , 2013, PloS one.
[14] P. Sullivan,et al. The increase in global HIV epidemics in MSM , 2013, AIDS.
[15] S. Moreno,et al. All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997–2010 , 2013, BMC Infectious Diseases.
[16] V. Valcour,et al. Management of human immunodeficiency virus infection in advanced age. , 2013, JAMA.
[17] R. Weber,et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study , 2013, HIV medicine.
[18] A. Phillips,et al. Life expectancy living with HIV: recent estimates and future implications , 2013, Current opinion in infectious diseases.
[19] Mardge H. Cohen,et al. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. , 2013, American journal of epidemiology.
[20] D. Forton,et al. Effect of hepatitis C virus on the central nervous system of HIV-infected individuals , 2012 .
[21] E. Szumilin,et al. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users , 2012, Tropical medicine & international health : TM & IH.
[22] L. Grothaus,et al. Chronic illness burden and quality of life in an aging HIV population , 2012, AIDS care.
[23] T. Niyonsenga,et al. Socioeconomic Status and Survival of People with Human Immunodeficiency Virus Infection before and after the Introduction of Highly Active Antiretroviral Therapy: A Systematic Literature Review , 2012, Journal of AIDS & clinical research.
[24] A. Esteve,et al. Factors associated with late presentation of HIV infection in Catalonia, Spain , 2012, International journal of STD & AIDS.
[25] D. Wantland,et al. Exploring the contribution of general self-efficacy to the use of self-care symptom management strategies by people living with HIV infection. , 2012, AIDS patient care and STDs.
[26] J. A. Caylà,et al. Retraso Diagnóstico de la Infección por VIH , 2012 .
[27] H. Putter,et al. Competing risks in epidemiology: possibilities and pitfalls. , 2012, International journal of epidemiology.
[28] O. Kirk,et al. The effect of injecting drug use history on disease progression and death among HIV‐positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis , 2012, HIV medicine.
[29] J. Blanco,et al. Educational Gradient in HIV Diagnosis Delay, Mortality, Antiretroviral Treatment Initiation and Response in a Country with Universal Health Care , 2012, Antiviral therapy.
[30] Margaret T May,et al. Life expectancy of HIV-positive adults: a review. , 2011, Sexual health.
[31] J. Castilla,et al. Educational level and HIV disease progression before and after the introduction of HAART: a cohort study in 989 HIV seroconverters in Spain , 2011, Sexually Transmitted Infections.
[32] J. Miro,et al. Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009 , 2011, AIDS research and therapy.
[33] J. Castilla,et al. Mortality by causes in HIV-infected adults: comparison with the general population , 2011, BMC public health.
[34] Carlos Del Rio,et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] N. Ford,et al. Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy , 2011, AIDS.
[36] D. Wantland,et al. Unhealthy substance-use behaviors as symptom-related self-care in persons with HIV/AIDS. , 2011, Nursing & health sciences.
[37] J. Caylà,et al. [Is it possible to reduce the delay in diagnosing HIV infection?]. , 2010, Enfermedades Infecciosas y Microbiologia Clinica.
[38] J. A. Caylà,et al. [Is it possible to reduce the delay in diagnosing HIV infection?]. , 2010, Enfermedades infecciosas y microbiologia clinica.
[39] J. Castilla,et al. Retraso diagnóstico de la infección por el virus de la inmunodeficiencia humana en España , 2010 .
[40] Ross J. Harris,et al. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] J. Carton,et al. Association of HIV transmission categories with sociodemographic, viroimmunological and clinical parameters of HIV-infected patients , 2009, Epidemiology and Infection.
[42] J. García,et al. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. , 2009, Enfermedades infecciosas y microbiologia clinica.
[43] T. Durant,et al. Late HIV Diagnosis and Determinants of Progression to AIDS or Death after HIV Diagnosis among Injection Drug Users, 33 US States, 1996–2004 , 2009, PloS one.
[44] Ross J. Harris,et al. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies , 2008, The Lancet.
[45] L. Berkman,et al. Unemployment as a risk factor for AIDS and death for HIV-infected patients in the era of highly active antiretroviral therapy , 2008, Sexually Transmitted Infections.
[46] J. Caylà,et al. Individual and community-level effects in the socioeconomic inequalities of AIDS-related mortality in an urban area of southern Europe , 2007, Journal of Epidemiology and Community Health.
[47] F. Lert,et al. Socioeconomic differences in the impact of HIV infection on workforce participation in France in the era of highly active antiretroviral therapy. , 2007, American journal of public health.
[48] J. Caylà,et al. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System? , 2006, European journal of public health.
[49] F. Lert,et al. Predictors identified for losses to follow-up among HIV-seropositive patients. , 2006, Journal of clinical epidemiology.
[50] G. Binefa,et al. [Survival changes among AIDS cases in Catalonia, Spain (1981-2001)]. , 2006, Medicina clínica (Ed. impresa).
[51] R. Gispert,et al. Cambio de la supervivencia de los casos de sida en Cataluña (1981-2001) , 2006 .
[52] Giuseppe Costa,et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations , 2005, The Lancet.
[53] Kholoud Porter,et al. Determinants of survival following HIV-1 seroconversion after the introduction of HAART , 2003, The Lancet.
[54] D. Osmond,et al. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. , 2002, The Journal of infectious diseases.
[55] Jonathan AC Sterne,et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies , 2002, The Lancet.
[56] J. González,et al. Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el virus de la inmunodeficiencia humana en el año 2002 , 2002 .
[57] J. Caylà,et al. Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV‐Infected Patients , 2002, Journal of acquired immune deficiency syndromes.
[58] K. Tashima,et al. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] D. Ng-Mak,et al. The Latino mortality paradox: a test of the "salmon bias" and healthy migrant hypotheses. , 1999, American journal of public health.
[60] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[61] A. Zuger. Adherence to highly active antiretroviral therapy. , 1997, AIDS clinical care.
[62] R. Scribner. Mortality among Hispanics. , 1994, JAMA.
[63] M. Sprangers,et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. , 2014, BMC medicine.
[64] Gabinet Tècnic de Programació. Distribució territorial de la renda familiar disponible per càpita a Barcelona. 2013 , 2014 .
[65] [Consensus Statement by GeSIDA/National AIDS Plan Secretariat on antiretroviral treatment in adults infected by the human immunodeficiency virus (Updated January 2013)]. , 2013, Enfermedades Infecciosas y Microbiologia Clinica.
[66] J. Caylà,et al. [Delay in diagnosis of HIV infection]. , 2012, Revista espanola de sanidad penitenciaria.
[67] J. Castilla,et al. [Delayed diagnosis of HIV infection in Spain]. , 2010, Enfermedades Infecciosas y Microbiologia Clinica.
[68] A. Orcau,et al. Increase in the non-HIV-related deaths among AIDS cases in the HAART era. , 2008, Current HIV research.
[69] J. Miro,et al. [Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002]. , 2002, Enfermedades infecciosas y microbiologia clinica.
[70] European Monitoring Center for Drugs and Drug Addiction. Annual Report on the State of the Drugs Problem in the European Union, Portugal, 1997 , 1998 .